» Articles » PMID: 10590103

RNA Dimerization Defect in a Rous Sarcoma Virus Matrix Mutant

Overview
Journal J Virol
Date 1999 Dec 10
PMID 10590103
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

The retrovirus matrix (MA) sequence of the Gag polyprotein has been shown to contain functions required for membrane targeting and binding during particle assembly and budding. Additional functions for MA have been proposed based on the existence of MA mutants in Rous sarcoma virus (RSV), murine leukemia virus, human immunodeficiency virus type 1, and human T-cell leukemia virus type 1 that lack infectivity even though they release particles of normal composition. Here we describe an RSV MA mutant with a surprising and previously unreported phenotype. In the mutant known as Myr1E, the small membrane-binding domain of the Src oncoprotein has been added as an N-terminal extension of Gag. While Myr1E is not infectious, full infectivity can be reestablished by a single amino acid substitution in the Src sequence (G2E), which eliminates the addition of myristic acid and the membrane-binding capacity of this foreign sequence. The presence of myristic acid at the N terminus of the Myr1E Gag protein does not explain its replication defect, because other myristylated derivatives of RSV Gag are fully infectious (e.g., Myr2 [C. R. Erdie and J. W. Wills, J. Virol. 64:5204-5208, 1990]). Biochemical analyses of Myr1E particles reveal that they contain wild-type levels of the Gag cleavage products, Env glycoproteins, and reverse transcriptase activity when measured on an exogenous template. Genomic RNA incorporation appears to be mildly reduced compared to the wild-type level. Unexpectedly, RNA isolated from Myr1E particles is monomeric when analyzed on nondenaturing Northern blots. Importantly, the insertional mutation does not lie within previously identified dimer linkage sites. In spite of the dimerization defect, the genomic RNA from Myr1E particles serves efficiently as a template for reverse transcription as measured by an endogenous reverse transcriptase assay. In marked contrast, after infection of avian cells, the products of reverse transcription are nearly undetectable. These findings might be explained either by the loss of a normal function of MA needed in the formation or stabilization of RNA dimers or by the interference in such events by the mutant MA molecules. It is possible that Myr1E viruses package a single copy of viral RNA.

Citing Articles

Dynamic interactions of retroviral Gag condensates with nascent viral RNA at transcriptional burst sites: implications for genomic RNA packaging.

Maldonado R, Parent L bioRxiv. 2025; .

PMID: 39829876 PMC: 11741468. DOI: 10.1101/2025.01.11.632546.


Visualizing Rous Sarcoma Virus Genomic RNA Dimerization in the Nucleus, Cytoplasm, and at the Plasma Membrane.

Chen E, Maldonado R, Parent L Viruses. 2021; 13(5).

PMID: 34068261 PMC: 8153106. DOI: 10.3390/v13050903.


Visualizing Association of the Retroviral Gag Protein with Unspliced Viral RNA in the Nucleus.

Maldonado R, Rice B, Chen E, Tuffy K, Chiari E, Fahrbach K mBio. 2020; 11(2).

PMID: 32265329 PMC: 7157774. DOI: 10.1128/mBio.00524-20.


RNA-Binding Domains of Heterologous Viral Proteins Substituted for Basic Residues in the RSV Gag NC Domain Restore Specific Packaging of Genomic RNA.

Rice B, Lochmann T, Parent L Viruses. 2020; 12(4).

PMID: 32230826 PMC: 7232437. DOI: 10.3390/v12040370.


Retroviral RNA Dimerization: From Structure to Functions.

Dubois N, Marquet R, Paillart J, Bernacchi S Front Microbiol. 2018; 9:527.

PMID: 29623074 PMC: 5874298. DOI: 10.3389/fmicb.2018.00527.


References
1.
Perez L, Davis G, Hunter E . Mutants of the Rous sarcoma virus envelope glycoprotein that lack the transmembrane anchor and cytoplasmic domains: analysis of intracellular transport and assembly into virions. J Virol. 1987; 61(10):2981-8. PMC: 255870. DOI: 10.1128/JVI.61.10.2981-2988.1987. View

2.
Sorge J, Ricci W, Hughes S . cis-Acting RNA packaging locus in the 115-nucleotide direct repeat of Rous sarcoma virus. J Virol. 1983; 48(3):667-75. PMC: 255399. DOI: 10.1128/JVI.48.3.667-675.1983. View

3.
Crawford S, Goff S . Mutations in gag proteins P12 and P15 of Moloney murine leukemia virus block early stages of infection. J Virol. 1984; 49(3):909-17. PMC: 255553. DOI: 10.1128/JVI.49.3.909-917.1984. View

4.
Dong J, Dubay J, Perez L, Hunter E . Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein define a requirement for dibasic residues for intracellular cleavage. J Virol. 1992; 66(2):865-74. PMC: 240787. DOI: 10.1128/JVI.66.2.865-874.1992. View

5.
Matthews S, Mikhailov M, Burny A, Roy P . The solution structure of the bovine leukaemia virus matrix protein and similarity with lentiviral matrix proteins. EMBO J. 1996; 15(13):3267-74. PMC: 451889. View